SuperGen, Astex Management Sell Merger Strategy To Investors
This article was originally published in The Pink Sheet Daily
After announcing a merger of the biotechs, management sought to convince investors the combination offers the best long-term value for both sides during an analyst day.
You may also be interested in...
The deal brings private Astex a long-sought NASDAQ listing and beefs up cash-rich SuperGen's lackluster pipeline.
The company is planning a direct-to-consumer education campaign to inform the public about the importance of vaccination.
The company showcased its pipeline in a two-day virtual meeting, trying to convince investors the long-term potential is undervalued.